Lupin Limited has informed the Exchange about press release dated 04-Nov-2022 titled Lupin Receives Tentative Approval from U.S. FDA for Drospirenone Tablets.
Lupin Limited has informed the Exchange about press release dated 04-Nov-2022 titled Lupin Receives Tentative Approval from U.S. FDA for Drospirenone Tablets.